The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index; 40 of the 148 sources its claims cite were checked for support.
Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission
Open accessAbstract
Aims/hypothesis: Weight reduction is fundamental for type 2 diabetes management and remission, but uncertainty exists over which diet type is best to achieve and maintain weight loss. We evaluated dietary approaches for weight loss, and remission, in people with type 2 diabetes to inform practice and clinical guidelines. Methods: First, we conducted a systematic review of published meta-analyses of RCTs of weight-loss diets. We searched MEDLINE (Ovid), PubMed, Web of Science and Cochrane Database of Systematic Reviews, up to 7 May 2021. We synthesised weight loss findings stratified by diet types and assessed meta-analyses quality with A Measurement Tool to Assess Systematic Reviews (AMSTAR) 2. We assessed certainty of pooled results of each meta-analysis using Grading of Recommendations, Assessment, Development and Evaluations (GRADE) (PROSPERO CRD42020169258). Second, we conducted a systematic review of any intervention studies reporting type 2 diabetes remission with weight-loss diets, in MEDLINE (via PubMed), Embase and Cochrane Central Register of Controlled Trials, up to 10 May 2021. Findings were synthesised by diet type and study quality (Cochrane Risk of Bias tool 2.0 and Risk Of Bias In Non-randomised Studies – of Interventions [ROBINS-I]), with GRADE applied (PROSPERO CRD42020208878). Results: We identified 19 meta-analyses of weight-loss diets, involving 2–23 primary trials ( n = 100–1587), published 2013–2021. Twelve were ‘critically low’ or ‘low’ AMSTAR 2 quality, with seven ‘high’ quality. Greatest weight loss was reported with very low energy diets, 1.7–2.1 MJ/day (400–500 kcal) for 8–12 weeks (high-quality meta-analysis, GRADE low), achieving 6.6 kg (95% CI −9.5, −3.7) greater weight loss than low-energy diets (4.2–6.3 MJ/day [1000–1500 kcal]). Formula meal replacements (high quality, GRADE moderate) achieved 2.4 kg (95% CI −3.3, −1.4) greater weight loss over 12–52 weeks. Low-carbohydrate diets were no better for weight loss than higher-carbohydrate/low-fat diets (high quality, GRADE high). High-protein, Mediterranean, high-monounsaturated-fatty-acid, vegetarian and low-glycaemic-index diets all achieved minimal (0.3–2 kg) or no difference from control diets (low to critically low quality, GRADE very low/moderate). For type 2 diabetes remission, of 373 records, 16 met inclusion criteria. Remissions at 1 year were reported for a median 54% of participants in RCTs including initial low-energy total diet replacement (low-risk-of-bias study, GRADE high), and 11% and 15% for meal replacements and Mediterranean diets, respectively (some concerns for risk of bias in studies, GRADE moderate/low). For ketogenic/very low-carbohydrate and very low-energy food-based diets, the evidence for remission (20% and 22%, respectively) has serious and critical risk of bias, and GRADE certainty is very low. Conclusions/interpretation: Published meta-analyses of hypocaloric diets for weight management in people with type 2 diabetes do not support any particular macronutrient profile or style over others. Very low energy diets and formula meal replacement appear the most effective approaches, generally providing less energy than self-administered food-based diets. Programmes including a hypocaloric formula ‘total diet replacement’ induction phase were most effective for type 2 diabetes remission. Most of the evidence is restricted to 1 year or less. Well-conducted research is needed to assess longer-term impacts on weight, glycaemic control, clinical outcomes and diabetes complications. Graphical abstract:
Overview
CoChat Summary
TL;DR
This umbrella review of meta-analyses and systematic review of remission trials found no clear superiority of any macronutrient profile or diet style for weight loss in adults with type 2 diabetes. Very low energy diets and formula meal replacement produced greater weight loss, and total diet replacement programmes were most effective for type 2 diabetes remission, but most evidence was limited to ≤1 year.
Key findings
- In 19 meta-analyses (2–23 primary trials; n = 100–1587), very low energy diets (1.7–2.1 MJ/day [400–500 kcal] for 8–12 weeks) achieved 6.6 kg greater weight loss than low-energy diets (95% CI −9.5, −3.7; high-quality meta-analysis, GRADE low). Formula meal replacements achieved 2.4 kg greater weight loss over 12–52 weeks (95% CI −3.3, −1.4; high quality, GRADE moderate).
- Low-carbohydrate diets were no better for weight loss than higher-carbohydrate/low-fat diets (high quality, GRADE high). High-protein, Mediterranean, high-monounsaturated-fatty-acid, vegetarian and low-glycaemic-index diets all achieved minimal (0.3–2 kg) or no difference from control diets (low to critically low quality, GRADE very low/moderate).
- For remission, 16 studies met inclusion criteria. At 1 year, median 54% remission (range 46–61%) was reported in RCTs including initial low-energy total diet replacement versus 4–12% in usual care (N = 445, 2 RCTs; GRADE high). Meal replacement achieved 11% versus 2% (N = 4503; GRADE moderate/low), and Mediterranean diet achieved 15% versus 4% (N = 215; GRADE low). Ketogenic/very low-carbohydrate and very low-energy food-based diets reported 20% and 22% remission, respectively, with serious/critical risk of bias and GRADE very low certainty.
- Single-arm/non-randomised studies reported higher remission than RCTs; shorter type 2 diabetes duration and Asian ethnicity were associated with greater likelihood of remission. Adherence up to 1 year was poorer with very low-carbohydrate diets (<50 g carbohydrate) than with low-carbohydrate diets (<130 g carbohydrate).
Methods
- Umbrella review of published meta-analyses of RCTs of weight-loss diets in type 2 diabetes; searched MEDLINE (Ovid), PubMed, Web of Science and Cochrane Database of Systematic Reviews to 7 May 2021; quality assessed with AMSTAR 2 and certainty with GRADE (PROSPERO CRD42020169258).
- Systematic review of any intervention studies reporting type 2 diabetes remission with weight-loss diets; searched MEDLINE (via PubMed), Embase and Cochrane Central Register of Controlled Trials to 10 May 2021; included RCTs and non-randomised studies, assessed with Cochrane Risk of Bias 2.0 and ROBINS-I, and GRADE (PROSPERO CRD42020208878). Findings were synthesised by diet type without meta-analysis due to limited and heterogeneous studies; intention-to-treat remission was computed when only completer data were reported.
Limitations
- The paper states that many included meta-analyses were of low or critically low AMSTAR 2 quality, predominantly because no protocol was reported and publication bias was not assessed; many had fewer than ten RCTs, limiting funnel-plot assessment. AMSTAR 2 criteria can be subjective, and if relaxed for protocol reporting and publication bias, the meta-analyses allow some confidence in the consistent findings of little/no difference between diets.
- The paper states that most included studies were in European participants, so results may not apply equally to other ethnic and/or deprived communities; South Asians may be more sensitive to weight loss. It also notes insufficient detail on macronutrient/micronutrient contents and prescribed/reported energy intakes, varied control diets, varied intervention durations, and that most evidence relates to ≤1 year.
- Evident from the text: remission evidence is limited, with only two RCTs having remission as the pre-specified outcome; many non-randomised studies had critical risk of bias, lacked comparator groups and/or randomisation, and may retain residual confounding. Some studies did not routinely withdraw glucose-lowering medications, so only minimum remissions can be reported, and no RCT evaluated low-carbohydrate/ketogenic diets for remission.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

![Fig. 2 All published meta-analyses of intervention diets vs control diets on weight loss (kg) stratified by overall quality in each diet type using AMSTAR 2 quality (green, high quality; orange, low quality; red, critically low quality). WMDs are presented alongside 95% CIs (error bars). Pooled results of McArdle et al., 2019 [34], Fan et al., 2016 [27], Zafar et al., 2019 [36] and Zhao et al., 2018 [30] are standardised mean differences. aComplete case data. GRADE level for certainty of evidence is rated as follows: ‘high’ indicates that we are very confident that the true effect lies close to that of the estimate of the effect; ‘moderate’ indicates that we are moderately confident in the effect estimate (the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different); ‘low’ indicates that our confidence in the effect estimate is limited (the true effect may be substantially different from the estimate of the effect); and ‘very low’ indicates that we have very little confidence in the effect estimate (the true effect is likely to be substantially different from the estimate of effect)](https://figures.cochat.ai/paper-figures/2d1d6a78db1745e88f536ce4e1adeb3f/diets-for-weight-management-in-adults-with-type-2-diabetes-an-umbrella-review-of-figure-2.jpg)


Verification
Claims the paper makes
17 Valid · 3 Not valid · 61 Not checked · 85 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Five studies compared diet interventions with usual care according to clinical guidelines, without providing foods or dietary products for participants [49–53].”
§ Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission > Results > (2) Systematic review of intervention studies (either RCTs or NRSs) of diets for remission of type 2 diabetes
What the sources say
- Could not verifycites [49] Gregg EW, Chen H, Wagenknecht LE et al (2012) Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA 308(23):2489–2496. https://doi.org/10.1001/jama.2012.67929 sourceExperimental — accuracy not yet measured
Our copy of Gregg et al. (2012) is the Look AHEAD trial report on diabetes remission; no passage enumerates or characterizes five diet-vs-usual-care trials, nor discusses whether foods or dietary products were supplied to participants. Searches for 'diet intervention compared with usual care without providing foods', 'meal replacements provided participants', 'five studies', and 'prior randomized trials diet clinical guidelines' returned only the study's own Intervention section (which states the opposite for Look AHEAD: 'Liquid meal replacements were provided to assist dietary goals') and reference-list entries such as Andrews et al.'s Early ACTID trial (ref 32). The Comment (references pp., section 'References') cites individual diet/usual-care and prevention trials but never aggregates them as five such studies, so the claim's point is not addressed in our copy. (LLM, conf=0.70)
- Supportedcites [50] Hallberg SJ, McKenzie AL, Williams PT et al (2018) Effectiveness and safety of a novel care model for the management of type 2 diabetes at 1 year: an open-label, non-randomized, controlled study. Diabetes Ther 9(2):583–612. https://doi.org/10.1007/s13300-018-0373-9 source
Hallberg et al. (2018) is exactly the kind of study the citing sentence enumerates: Methods (Continuous Care Intervention) describe individualized nutrition recommendations targeting nutritional ketosis, compared against a Usual Care cohort (Methods, Usual Care) whose care was unmodified by the study and followed local diabetes education/standard medical care cited to the ADA Standards of Medical Care in Diabetes (ref [7]). The Discussion (Study Strengths and Weaknesses) explicitly lists 'lack of food provision' as a feature of the trial, so no foods or dietary products were supplied; supplements (multivitamin, vitamin D3, omega-3, magnesium) appear only as advice, not provision. The count of five studies is the citing paper's synthesis across refs 49-53, of which this source is one verified example. (LLM, conf=0.86)
- Disputedcites [51] Lean ME, Leslie WS, Barnes AC et al (2018) Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet 391(10120):541–551. https://doi.org/10.1016/S0140-6736(17)33102-1 sourceExperimental — accuracy not yet measured
DiRECT does match the 'diet intervention vs usual care under clinical guidelines' half of the claim: Randomisation and masking states practices were assigned to the Counterweight-Plus programme 'or best-practice care by guidelines (control)', and Procedures notes both groups continued diabetes care under NICE and SIGN guidelines. But it contradicts the qualifier 'without providing foods or dietary products': Procedures (Participants in the intervention group...) describes a total diet replacement phase using a low energy formula diet (825-853 kcal/day) for 3 months, and Acknowledgements state 'The formula diet was donated by Cambridge Weight Plan', i.e. a proprietary dietary product was supplied to intervention participants (along with step counters at food reintroduction). So this trial belongs to the opposite category from the one the citing sentence assigns it. (LLM, conf=0.80)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [52] Mollentze WF, Joubert G, Prins A, van der Linde S, Marx GM, Tsie KG (2019) The safety and efficacy of a low-energy diet to induce weight loss, improve metabolic health, and induce diabetes remission in insulin-treated obese men with type 2 diabetes: a pilot RCT. Int J Diabetes Dev C 39(4):618–625. https://doi.org/10.1007/s13410-019-00734-1 sourceExperimental — accuracy not yet measured
Our copy confirms only that this is an RCT comparing a diet intervention with a non-diet-product control arm: the Study design section describes a 6-month comparison of 'a commercial weight loss program with a standard nutrition intervention', and the Control group section (p. n/a) says a dietitian gave each control subject 'a balanced personalized energy-restricted meal plan'. Two elements of the claim are not supported: the comparator is not described as 'usual care according to clinical guidelines' — control subjects also received the same 2-h interactive training programme as the intervention arm and weekly facility visits for insulin adjustment, and no passage ties the control plan to SEMDSA or any guideline (reference 22 to the SEMDSA medical nutrition therapy guideline appears only in the reference list). The 'without providing foods or dietary products' qualifier is also not established: the intervention arm's plan was built around a commercial dietary product (CSN vegetable soup reconstituted from desiccated vegetable powder), and our copy nowhere states that no foods or products were supplied. (LLM, conf=0.65)
- Not checked yetcites [53] Taheri S, Zaghloul H, Chagoury O et al (2020) Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial. Lancet Diabetes Endocrinol 8(6):477–489. https://doi.org/10.1016/S2213-8587(20)30117-0 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“In the Doctor Referral of Overweight People to Low Energy total diet replacement Treatment (DROPLET) trial among people without diabetes, in routine practice, a total diet replacement programme (formula diets) with behavioural support proved more cost-effective than nurse-led dietary advice for long-term prevention of obesity-related diseases [62].”
§ Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission > Discussion > Dietary weight reduction for people with type 2 diabetes
What the sources say
- Disputedcites [62] Kent S, Aveyard P, Astbury N, Mihaylova B, Jebb SA (2019) Is doctor referral to a low-energy total diet replacement program cost-effective for the routine treatment of obesity? Obesity (Silver Spring) 27(3):391–398. https://doi.org/10.1002/oby.22407 sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 1 partially supported, 1 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“We first included RCTs reporting type 2 diabetes remission as the primary outcome, the design most likely to provide trustworthy evidence. However, as few such RCTs have been conducted, we also evaluated non-randomised studies (NRSs) to capture the totality of the evidence for ‘best available advice’ to inform practice and policy [20].”
§ Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission > Methods > (2) Systematic review of diets for type 2 diabetes remission
What the sources say
- Could not verifycites [20] Schunemann HJ, Tugwell P, Reeves BC et al (2013) Non-randomized studies as a source of complementary, sequential or replacement evidence for randomized controlled trials in systematic reviews on the effects of interventions. Res Synth Methods 4(1):49–62. https://doi.org/10.1002/jrsm.1078 sourceExperimental — accuracy not yet measured
The source discusses when non-randomized studies can complement limited RCT evidence (section 3.1, p. 8), but it does not say how many RCTs have examined type 2 diabetes remission as a primary outcome. Searches for that outcome and for diabetes-remission trials found no passage addressing the claim. (LLM, conf=0.76)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Most meta-analyses were of critically low (n = 7; [25–31]) to low quality (n = 5; [32–36]).”
§ Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission > Results > (1) Umbrella review of published meta-analyses of RCTs of diets for weight loss and glycaemic control
What the sources say
- Not checked yetcites [25] Pan B, Wu Y, Yang Q et al (2019) The impact of major dietary patterns on glycemic control, cardiovascular risk factors, and weight loss in patients with type 2 diabetes: a network meta-analysis. J Evid Based Med 12(1):29–39. https://doi.org/10.1111/jebm.12312 source
- Supportedcites [26] Ajala O, English P, Pinkney J (2013) Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes. Am J Clin Nutr 97(3):505–516. https://doi.org/10.3945/ajcn.112.042457 source
The Statistical analysis section states that the paper undertook meta-analyses of dietary-intervention subgroups. The citation identifies this paper as one of the meta-analyses assessed; the critically low quality rating is the citing authors’ assessment, not a finding attributed to this paper. (LLM, conf=0.87)
- Not checked yetcites [27] Fan YF, Di HJ, Chen GF, Mao XD, Liu C (2016) Effects of low carbohydrate diets in individuals with type 2 diabetes: systematic review and meta-analysis. Int J Clin Exp Med 9(6):11166–11174
- Could not verifycites [28] Pfeiffer AFH, Pedersen E, Schwab U et al (2020) The effects of different quantities and qualities of protein intake in people with diabetes mellitus. Nutrients 12(2):365. https://doi.org/10.3390/nu12020365 sourceExperimental — accuracy not yet measured
The Methods section describes GRADE evidence categories, and §2.2 says available meta-analyses did not meet the authors’ inclusion criteria. Neither passage rates seven meta-analyses as critically low quality or five as low quality; searches for those counts and for a critically low quality assessment found no such passage in our copy. (LLM, conf=0.74)
- Not checked yetcites [29] Qian F, Korat AA, Malik V, Hu FB (2016) Metabolic effects of monounsaturated fatty acid-enriched diets compared with carbohydrate or polyunsaturated fatty acid-enriched diets in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabetes Care 39(8):1448–1457. https://doi.org/10.2337/dc16-0513 source
- Supportedcites [30] Zhao WT, Luo Y, Zhang Y, Zhou Y, Zhao TT (2018) High protein diet is of benefit for patients with type 2 diabetes: an updated meta-analysis. Medicine 97(46):e13149. https://doi.org/10.1097/MD.0000000000013149 source
The citation identifies one of the meta-analyses assessed by the citing authors. The Results, under “Characteristics of included studies,” state that this paper included 18 studies in its meta-analysis. The critically-low rating and the counts are the citing authors’ assessment, not findings attributed to this source. (LLM, conf=0.85)
- Supportedcites [31] Snorgaard O, Poulsen GM, Andersen HK, Astrup A (2017) Systematic review and meta-analysis of dietary carbohydrate restriction in patients with type 2 diabetes. BMJ Open Diabetes Res Care 5(1):e000354. https://doi.org/10.1136/bmjdrc-2016-000354 source
The citation identifies one of the meta-analyses assessed by the citing authors, rather than attributing the quality counts to this paper. The source is itself a systematic review and meta-analysis, as its title states; its Results section discusses its evaluation of other reviews. The critically low and low ratings are the citing authors’ assessments, not findings this source needs to report. (LLM, conf=0.84)
- Not checked yetcites [32] Huo R, Du T, Xu Y et al (2015) Effects of Mediterranean-style diet on glycemic control, weight loss and cardiovascular risk factors among type 2 diabetes individuals: a meta-analysis. Eur J Clin Nutr 69(11):1200–1208. https://doi.org/10.1038/ejcn.2014.243 source
- Not checked yetcites [33] Meng Y, Bai H, Wang S, Li Z, Wang Q, Chen L (2017) Efficacy of low carbohydrate diet for type 2 diabetes mellitus management: a systematic review and meta-analysis of randomized controlled trials. Diabetes Res Clin Pract 131:124–131. https://doi.org/10.1016/j.diabres.2017.07.006 source
- Partly supportedcites [34] McArdle PD, Greenfield SM, Rilstone SK, Narendran P, Haque MS, Gill PS (2019) Carbohydrate restriction for glycaemic control in type 2 diabetes: a systematic review and meta-analysis. Diabet Med 36(3):335–348. https://doi.org/10.1111/dme.13862 sourceExperimental — accuracy not yet measured
The Data Sources and Searches section (p. 5) identifies this work as a systematic review and meta-analysis, so it can serve as an example of a meta-analysis. The Data Extraction and Quality Assessment section (p. 5) assesses bias in included studies, not the quality of meta-analyses; our copy does not substantiate the critically low or low ratings or the counts of seven and five. (LLM, conf=0.80)
plainn = 7- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A non-diabetic state can be restored for 2 years for 70–80% of people with type 2 diabetes by interventions that maintain over 10 kg weight loss (36/149, 24% of participants in the Diabetes Remission Clinical Trial [DiRECT]) [7], which sustains loss of ectopic fat, reversing the pathophysiology and normalising pancreas morphology [8].”
§ Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission > Introduction
What the sources say
- Partly supportedcites [7] Thom G, Messow CM, Leslie WS et al (2021) Predictors of type 2 diabetes remission in the diabetes remission clinical trial (DiRECT). Diabet Med 38(8):e14395. https://doi.org/10.1111/dme.14395 sourceExperimental — accuracy not yet measured
Figure 2 reports remission at two years in 78.9% of participants who lost 10–<15 kg and 82.4% of those who lost ≥15 kg; its counts show that 36/149 participants maintained a loss of at least 10 kg. The claim broadly says “people with type 2 diabetes,” but the Discussion says DiRECT studied people with relatively short-duration diabetes, predominantly white Europeans, and that evidence is needed for people with longer disease duration and other ethnicities. (LLM, conf=0.88)
- Partly supportedcites [8] Al-Mrabeh A, Hollingsworth KG, Shaw JAM et al (2020) 2-year remission of type 2 diabetes and pancreas morphology: a post-hoc analysis of the DiRECT open-label, cluster-randomised trial. Lancet Diabetes Endocrinol 8(12):939–948. https://doi.org/10.1016/S2213-8587(20)30303-X sourceExperimental — accuracy not yet measured
The Introduction reports that DiRECT achieved non-diabetic blood glucose control for two years, but gives 36% of the intervention group, not 70–80%. The Clinical and metabolic studies section describes weight maintenance through 24 months, but our copy does not establish the claimed 70–80% remission rate among people maintaining more than 10 kg of weight loss. In the citing sentence, this paper is cited for the subsequent pancreas-morphology claim, which its Discussion supports. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
91 more claims · 8 with their cited sources checked
Create a free account to see all 166 claims and to verify the 108 references still open.
- Probably not a substantial claim. 32
- It may state two separate claims as one. 46
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While bariatric surgery has established that long-term type 2 diabetes remission is possible for many, with reduced clinical events, 36,37”
From 5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study (2024) · cites this paper as [36]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“VLCDs are very effective at achieving weight loss and significant improvement in cardiometabolic parameters in short periods [221,222], including diabetes remission”
From Lifestyle Medicine for Obesity in the Era of Highly Effective Anti-Obesity Treatment (2025) · cites this paper as [223]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“As a result, the evidence does not identify one eating plan or a certain macronutrient composition that is clearly superior to other [177] and can be generally recommended for weight loss for people with T2DM [178].”
From Effects of diet, lifestyle, Chrononutrition and alternative dietary interventions on postprandial Glycemia and insulin resistance (2022) · cites this paper as [177]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission > Results > (2) Systematic review of intervention studies (either RCTs or NRSs) of diets for remission of type 2 diabetes
“compared with 2% (43/2170) in standard care (N = 4503; GRADE low certainty of evidence)”
§ Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission > Results > (2) Systematic review of intervention studies (either RCTs or NRSs) of diets for remission of type 2 diabetes
“| Meal replacement | Meal replacement likely leads to T2D remission by 11% from baseline, when compared with standard care plus diabetes education (2%). | 4503 (1 RCT) | ⊕⊕◯MODERATEDue to possible publication bias |”
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission > Results > (1) Umbrella review of published meta-analyses of RCTs of diets for weight loss and glycaemic control
“One high-quality meta-analysis [43] of two RCTs reported that VLEDs”
§ Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission > Results > (1) Umbrella review of published meta-analyses of RCTs of diets for weight loss and glycaemic control
“| Rehackova et al., 2016 [43] | Low |”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission > Results > (1) Umbrella review of published meta-analyses of RCTs of diets for weight loss and glycaemic control
“Most meta-analyses were of critically low (n = 7; [25–31]) to low quality (n = 5; [32–36]).”
§ Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission > Results > (1) Umbrella review of published meta-analyses of RCTs of diets for weight loss and glycaemic control
“| Zafar et al., 2019 [36] | Critically low |”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“For completer analysis, remission rate was 4.6% calculated from 52 out of 88 completers”
§ Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission > Results > (2) Systematic review of intervention studies (either RCTs or NRSs) of diets for remission of type 2 diabetes
Reported 4.6 · recomputed 59.090909
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission > Results > (2) Systematic review of intervention studies (either RCTs or NRSs) of diets for remission of type 2 diabetes
“1 yr: 71.1% (32/45)5 yr: 42.2%h (19/45)”
§ Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission > Results > (2) Systematic review of intervention studies (either RCTs or NRSs) of diets for remission of type 2 diabetes
“For completer analysis, remission rate was 46.3% calculated from available data at 12 months (19 out of 41 completers)”
2 more findings
Create a free account to see every finding of this check.
Citations
Cites
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283
RoB 2: a revised tool for assessing risk of bias in randomised trials
Sterne, J. A. C., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., Cates, C. J., Cheng, H.-Y., Corbett, M. S., Eldridge, S. M., et al. (2019) · BMJ · doi:10.1136/bmj.l4898 · Cited by 34,787
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Sterne, J. A., Hernán, M. A., Reeves, B. C., Savović, J., Berkman, N. D., Viswanathan, M., Henry, D., Altman, D. G., Ansari, M. T., Boutron, I., et al. (2016) · BMJ · doi:10.1136/bmj.i4919 · Cited by 20,329
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J., Bossuyt, P., Boutron, I., Hoffmann, T., mulrow, C., Shamseer, L., Tetzlaff, J., Akl, E., Brennan, S. E., et al. (2020) · doi:10.31222/osf.io/v7gm2 · Cited by 5,177
Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline
Campbell, M., McKenzie, J. E., Sowden, A., Katikireddi, S. V., Brennan, S. E., Ellis, S., Hartmann-Boyce, J., Ryan, R., Shepperd, S., Thomas, J., et al. (2020) · BMJ · doi:10.1136/bmj.l6890 · Cited by 4,628 · cited 1×
“Our paper is written in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 [18] and the Synthesis Without Metaanalysis in systematic reviews: reporting guideline [19].”
MethodFerence, B. A., Ginsberg, H. N., Graham, I., Ray, K. K., Packard, C. J., Bruckert, E., Hegele, R. A., Krauss, R. M., Raal, F. J., Schunkert, H., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx144 · Cited by 3,962
Lean, M. E., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Peters, C., Zhyzhneuskaya, S., Al-Mrabeh, A., Hollingsworth, K. G., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33102-1 · Cited by 2,095 · cited 3×
“Most type 2 diabetes is treated in primary care, the setting for both published remission trials using an intensive ‘total diet replacement’ induction phase with formula diets [51].”
BackgroundResultSelf-citation
Research works printed but not linked: 1
- Fan YF, Di HJ, Chen GF, Mao XD, Liu C (2016) Effects of low carbohydrate diets in individuals with type 2 diabetes: systematic review and meta-analysis. Int J Clin Exp Med 9(6):11166–11174
Cited by
Ahmad, E., Lim, S., Lamptey, R., Webb, D. R., & Davies, M. J. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01655-5 · Cited by 1,120
Evidence-based European recommendations for the dietary management of diabetes
The Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD), Aas, A.-M., Axelsen, M., Churuangsuk, C., Hermansen, K., Kendall, C. W. C., Kahleova, H., Khan, T., Lean, M. E. J., Mann, J. I., et al. (2023) · Diabetologia · doi:10.1007/s00125-023-05894-8 · Cited by 262
Self-citationPapakonstantinou, E., Oikonomou, C., Nychas, G., & Dimitriadis, G. D. (2022) · Nutrients · doi:10.3390/nu14040823 · Cited by 199
Lean, M. E., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Kelly, T., Irvine, K., Peters, C., Zhyzhneuskaya, S., et al. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00385-6 · Cited by 186
Self-citationUltraprocessed Foods and Obesity Risk: A Critical Review of Reported Mechanisms
Valicente, V. M., Peng, C.-H., Pacheco, K., Lin, L., Kielb, E., Dawoodani, E., Abdollahi, A., & Mattes, R. D. (2023) · Advances in Nutrition · doi:10.1016/j.advnut.2023.04.006 · Cited by 181
Metadata
- Authors
- Churuangsuk, C., Hall, J., Reynolds, A., Griffin, S. J., Combet, E., & Lean, M. E. J.
- Affiliations
- Prince of Songkla University (TH)
- University of Glasgow (GB)
- University of Otago (NZ)
- University of Cambridge (GB)
- Corresponding author
- Lean, Michael E. J.
- ORCID
- Venue
- Diabetologia
- Published
- 2021-11-17
- Volume
- 65
- Issue
- 1
- Pages
- 14-36
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- PMC
- PMC8660762
- OpenAlex
- W3191307854
- Semantic Scholar
- 54e916ea7ac77f19855fef08c2849bca101e9ad7
- Cited by
- 204
- References
- 105
- Citations by year
- 2026: 27 · 2025: 55 · 2024: 47 · 2023: 44 · 2022: 29 · 2021: 1
- FWCI
- 4.04
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Diabetologia (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by-sa)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo (cc-by)
- Funders
- National Institute for Health and Care Research
- University of Glasgow
- Topics
- Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
- Keywords
- type 2 diabetes, weight loss diet, diabetes remission, weight management, very low calorie diet, hypocaloric diet, low-carbohydrate diet, low-fat diet, Mediterranean diet
- MeSH terms
- Systematic Reviews as Topic, Adult, Clinical Trials as Topic, Diabetes Mellitus, Type 2, Humans, Meta-Analysis as Topic, Weight Loss, Diet, Fat-Restricted, Diet, Carbohydrate-Restricted
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission. https://app.cochat.ai/papers/10.1007/s00125-021-05577-2
- The paper
- Churuangsuk, C., Hall, J., Reynolds, A., Griffin, S. J., Combet, E., & Lean, M. E. J. (2022). Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission. Diabetologia. https://doi.org/10.1007/s00125-021-05577-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.